Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Conno

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Journal of Pain and Symptom Management|April 17, 2001
Differences in gabapentin efficacy for cancer pain more apparent than real?A Caraceni, E Zecca, C Martini, et al.
Lancet (London, England)|May 4, 1996
Morphine for relief of cancer painC Ripamonti, F De Conno, H Blumhuber, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 13, 2001
Palliative care at the National Cancer Institute of MilanF De Conno, C Ripamonti, A Caraceni, et al.
Journal of Pain and Symptom Management|November 1, 1994
Organic brain syndromes and opioid administration for cancer painA Caraceni, C Martini, F De Conno, et al.
Journal of Palliative Care|October 15, 1998
Eighteen years of home care: from assistance by phone to a complete service within the health care systemF De Conno, R Boffi, L Saita, et al.
International Journal of Tissue Reactions|January 1, 1985
WHO guidelines for the use of analgesics in cancer painV Ventafridda, L Saita, C Ripamonti, et al.
Minerva Medica|August 15, 1987
[Buprenorphine in cancer pain: cross comparison with pentazocine]F De Conno, C Ripamonti, M Tamburini, et al.
Journal of Palliative Care|January 1, 1993
A clinical note on sublingual buprenorphineF De Conno, C Ripamonti, A Sbanotto, et al.
Tumori|July 1, 1996
Role of enteral nutrition in advanced cancer patients: indications and contraindications of the different techniques employedC Ripamonti, B T Gemlo, F Bozzetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2010
Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy InitiativeN I Cherny, J Baselga, F de Conno, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Journal of Pain and Symptom Management|April 17, 2001
Differences in gabapentin efficacy for cancer pain more apparent than real?A Caraceni, E Zecca, C Martini, et al.
Lancet (London, England)|May 4, 1996
Morphine for relief of cancer painC Ripamonti, F De Conno, H Blumhuber, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 13, 2001
Palliative care at the National Cancer Institute of MilanF De Conno, C Ripamonti, A Caraceni, et al.
Journal of Pain and Symptom Management|November 1, 1994
Organic brain syndromes and opioid administration for cancer painA Caraceni, C Martini, F De Conno, et al.
Journal of Palliative Care|October 15, 1998
Eighteen years of home care: from assistance by phone to a complete service within the health care systemF De Conno, R Boffi, L Saita, et al.
International Journal of Tissue Reactions|January 1, 1985
WHO guidelines for the use of analgesics in cancer painV Ventafridda, L Saita, C Ripamonti, et al.
Minerva Medica|August 15, 1987
[Buprenorphine in cancer pain: cross comparison with pentazocine]F De Conno, C Ripamonti, M Tamburini, et al.
Journal of Palliative Care|January 1, 1993
A clinical note on sublingual buprenorphineF De Conno, C Ripamonti, A Sbanotto, et al.
Tumori|July 1, 1996
Role of enteral nutrition in advanced cancer patients: indications and contraindications of the different techniques employedC Ripamonti, B T Gemlo, F Bozzetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2010
Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy InitiativeN I Cherny, J Baselga, F de Conno, et al.
Pageof 11